Caitong International Asset Management Co., LTD Atai Life Sciences N.V. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 386 shares of ATAI stock, worth $887. This represents 0.0% of its overall portfolio holdings.
Number of Shares
386
Previous 386
-0.0%
Holding current value
$887
Previous $513,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
104Shares Held
16.3MCall Options Held
367KPut Options Held
69.2K-
Morgan Stanley New York, NY3.33MShares$7.66 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$4.46 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$3.01 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$2.26 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$2.18 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $382M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...